LX111
/ Innostellar Biotherap
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 11, 2026
Safety and Efficacy Evaluation of LX111 Gene Therapy in DME Patients
(clinicaltrials.gov)
- P1 | N=32 | Recruiting | Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Not yet recruiting ➔ Recruiting
Enrollment open • Diabetic Macular Edema • Gene Therapies • Ophthalmology
January 24, 2026
Safety and Efficacy Evaluation of LX111 Gene Therapy in DME Patients
(clinicaltrials.gov)
- P1 | N=32 | Not yet recruiting | Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
New P1 trial • Diabetic Macular Edema • Gene Therapies • Ophthalmology
1 to 2
Of
2
Go to page
1